Given sustained healthcare spending owing to an increasing frequency of chronic diseases and the rapidly aging population worldwide combined with growing research and development (R&D) efforts, the pharmaceutical industry’s outlook radiates promise. Further, digital transformation is revolutionizing drug discovery and manufacturing processes, driving the industry’s growth.
Considering the industry’s tailwinds, it could be wise to invest in fundamentally sound pharma stocks Wave Life Sciences Ltd. (WVE), Teva Pharmaceutical Industries Limited (TEVA), and Collegium Pharmaceutical, Inc. (COLL) for potential gains.
